EFFICIENCY OF THE NITRIC OXIDE DONOR MOLSIDOMINE IN THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
According to the results of the latest trials of molsidomine, the latter promotes the decelerated development and stabilization of atherosclerotic plaques. This allows the use of molsidomine to prevent restenoses and opens up fresh opportunities for the treatment of coronary heart disease.